TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

PACS Group, Inc. (PACS)

Healthcare Medical Care Facilities
46.00 $
-2.1% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at PACS Group, Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 2 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Trading Day

Previous Close
47.00$
Open
47.40$
Day High
47.90$
Day Low
45.80$
Volume
798,450shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
7.70 $ 47.10 $
09/10/2025 07/27/2026

Current price 46.00 $ — 97% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
7.1$B
Shares Outstanding
158Mio.
Float
30.2%
Beta
-0.1

Performance

Perf. 1M
5.10%
Perf. 3M
30.60%
Perf. 6M
7.00%
YTD Performance (%)
-2.70%
52-Week-High Distance
-5.6%
Perf. 1Y
316.00%
Perf. 5Y
68.91%
Perf. Since Inception
100.04%

Technical Indicators

MA 38 Days
41.90$
MA 50 Days
40.80$
MA 200 Days
33.70$
RSI (14)
59.6
Volatility 30 Days
41.7%
Volatility 250 Days
92.4%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
Forward P/E
20.3
PEG
1.4
P/B
P/S
1.3
EV/EBITDA
23.4
Price/FCF
30.1

Profitability

Gross Margin
16.8%
EBIT Margin
8.5%
Net Margin
4.5%
Return on Equity
27.1%
Return on Assets
4.3%

Balance Sheet & Safety

Equity Ratio
18.3%
Debt/Equity
Altman Z″
4.16
Piotroski
7 out of 9

Growth

Sales Growth Last Quarter
11.20%
EPS Growth Last Quarter
194.10%
Sales Growth (Year)
29.32%
Forward Sales Growth
6.64%
Forward EPS Growth
31.90%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
2
Top 10%
RS Rating
92
Top 10%
EPS Rating
90
Piotroski
7 out of 9
Fundamental Rating
B (73 out of 100)
Altman Z″
4.16

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Growth Score

5 of 10 Solid growth

Ten checks against the annual reports — each one passed counts a point.

  • Revenue grows by more than 15% a year over three years 29.7% passed
  • More than 10% revenue growth is expected for the coming year 6.6% failed
  • Share count grows by less than 3% a year 1.4% passed
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 35.0% failed
  • Gross margin at 40% or higher and without meaningful erosion 21.9% failed
  • Goodwill from acquisitions does not grow faster than revenue 1.1% passed
  • Net debt below twice EBITDA 9.3 x EBITDA failed
  • Operating cash flow covers the profits of the last three years 475 m passed
  • Return on capital at 15% or higher, or up versus two years ago 6.8% failed
  • Insiders hold at least 10% or are net buyers 70.2% passed

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 46.00 $
Price Target (average) 52.67 $

The price target sits 14.5% above the current price.

Consensus
Strong Sell
Analyst Ratings
4
Distribution of Recommendations
Strong Buy 3
Buy 1
Hold 0
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 2.32 2.30 – 2.34 5,712 28.5% 3
12/31/2027 2.45 2.44 – 2.45 6,045 5.3% 3

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

4. Aug 2026 · after the close · Q2 2026
Expected Earnings per Share
0.55 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 1,207.9 $M Q4 2025: Q1 · 1,277.2 $M Q1 2025: Q2 · 1,309.2 $M Q2 2025: Q3 · 1,344.6 $M Q3 2025: Q4 · 1,358.0 $M Q4 2026: Q1 · 1,420.5 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.24 6.20 1,208 41.60 3.10 65 -19
2025: Q1 0.18 -44.80 1,277 36.60 2.20 150 133
2025: Q2 0.33 1,309 33.30 3.90 53 34
2025: Q3 0.32 216.10 1,345 31.00 3.90 205 106
2025: Q4 0.38 58.90 1,358 12.40 4.40 -3 -118
2026: Q1 0.50 171.30 1,421 11.20 5.70 236 215
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2021 1,167 83 48 0.32 58
2022 2,422 229 151 1.00 93 64 2,462
2023 3,111 208 113 0.75 64 96 3,513
2024 4,090 123 56 0.36 367 716 5,243
2025 5,289 310 192 1.22 404 947 5,584

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

PACS Group, Inc. betreibt über seine Tochtergesellschaften Pflegeeinrichtungen und betreutes Wohnen in den USA.

Employees47,455
HeadquartersSalt Lake City, UT
Address90 S. 400 W, 84101 Salt Lake City, United States
Phone801 447 9829
Websitepacs.com
IPO Date11. Apr 2024
ISINUS69380Q1076

Management

Management
Name Title Birth Year
Jason Murray Co-Founder, CEO & Chairman 1980
Joshua Jergensen President & COO 1985
Michelle Lewis Chief Accounting Officer 1977
John Todd Mitchell Esq. Chief Legal Officer & Secretary 1976
Carey P. Hendrickson Chief Financial Officer 1962
Kelly Priegnitz Chief Compliance Officer 1964
Trent Bingham Chief Human Resources Officer 1972
Ryan Welch Director of Corporate Finance

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
15. Jul 2026 Hancock Mark Director Sell 3,332 45.05 150,115
15. Jul 2026 Jergensen Joshua President & COO Sell 233 45.76 10,662
15. Jul 2026 Jergensen Joshua President & COO Sell 32,327 45.13 1,458,989
15. Jul 2026 Jergensen Joshua President & COO Sell 7,440 44.50 331,067
14. Jul 2026 Hancock Mark Director Sell 10,296 45.04 463,680

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?